• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有症状的良性前列腺增生症的活跃男性的生活质量:治疗效果。

Quality of life in sexually active men with symptomatic benign prostatic hyperplasia : effects of treatment.

机构信息

SubAcute Unit, Geriatric Medicine, Greater Baltimore Medical Center, Baltimore, Maryland, USAJohns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Clin Drug Investig. 2005;25(4):219-30. doi: 10.2165/00044011-200525040-00001.

DOI:10.2165/00044011-200525040-00001
PMID:17523772
Abstract

Quality of life (QOL), sexuality in particular, has become an important consideration in treatment decisions for men with lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH). To determine the impact of these conditions on sexual function and QOL in older men, this article provides a review of clinical data on the relationship between sexual dysfunction and symptom severity, effective clinical assessment, treatment options, and the influence of current therapies on sexual function and QOL. The various symptoms of BPH can adversely affect sexual functioning and therefore QOL. Moreover, there may be a direct association between symptom severity and sexual dysfunction that may affect QOL.Patients base their decisions regarding treatment choices for BPH more on anticipated relief of lower urinary tract symptoms and improved QOL (including sexual functioning) than on improvements in physical measures. Although medications and surgery may relieve LUTS, sexual dysfunction is a common adverse result. Newer pharmacological interventions such as specific alpha-adrenergic blocking agents like tamsulosin may help improve sexual function and QOL in men with symptomatic BPH.

摘要

生活质量(QOL),尤其是性功能,已成为治疗与良性前列腺增生(BPH)相关下尿路症状(LUTS)男性的重要考虑因素。为了确定这些情况对老年男性性功能和生活质量的影响,本文综述了性功能障碍与症状严重程度、有效临床评估、治疗选择以及当前治疗方法对性功能和生活质量影响之间关系的临床数据。BPH 的各种症状会对性功能产生不利影响,从而影响生活质量。此外,症状严重程度与性功能障碍之间可能存在直接关联,从而影响生活质量。患者在选择 BPH 治疗方案时,更多地基于对下尿路症状缓解和生活质量(包括性功能)改善的预期,而不是基于身体指标的改善。尽管药物治疗和手术可以缓解 LUTS,但性功能障碍是常见的不良后果。新型药物干预措施,如特定的α肾上腺素能阻滞剂(如坦索罗辛),可能有助于改善有症状的 BPH 男性的性功能和生活质量。

相似文献

1
Quality of life in sexually active men with symptomatic benign prostatic hyperplasia : effects of treatment.有症状的良性前列腺增生症的活跃男性的生活质量:治疗效果。
Clin Drug Investig. 2005;25(4):219-30. doi: 10.2165/00044011-200525040-00001.
2
Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.良性前列腺增生症下尿路症状的治疗及其对性功能的影响。
Clin Ther. 2006 Jan;28(1):13-25. doi: 10.1016/j.clinthera.2006.01.004.
3
Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.疑似良性前列腺增生的下尿路症状的治疗:性功能
BJU Int. 2005 Jun;95 Suppl 4:12-8. doi: 10.1111/j.1464-410X.2005.05486.x.
4
Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.当前良性前列腺增生症的治疗:对性功能的影响及相关性功能不良事件的管理。
Int J Clin Pract. 2011 Sep;65(9):1005-13. doi: 10.1111/j.1742-1241.2011.02731.x. Epub 2011 Jul 1.
5
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.良性前列腺增生所致下尿路症状与性功能障碍关系的批判性分析。
Eur Urol. 2011 Oct;60(4):809-25. doi: 10.1016/j.eururo.2011.06.037. Epub 2011 Jun 29.
6
Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).与良性前列腺增生(BPH)相关的性功能障碍和下尿路症状(LUTS)。
Eur Urol. 2005 Jun;47(6):824-37. doi: 10.1016/j.eururo.2004.12.013. Epub 2005 Jan 5.
7
An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.一项亚洲多国针对良性前列腺增生患者的前瞻性观察性登记研究,重点关注合并症、下尿路症状和性功能。
BJU Int. 2008 Jan;101(2):197-202. doi: 10.1111/j.1464-410X.2007.07320.x. Epub 2007 Nov 13.
8
Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.坦索罗辛对良性前列腺增生症患者总体及症状特异性生活质量的临床影响:采用国际前列腺症状评分和兰德医疗结局研究36项健康调查
Int J Urol. 2006 Sep;13(9):1202-6. doi: 10.1111/j.1442-2042.2006.01594.x.
9
[Impact of alfuzosin 10 mg once daily on quality of life in Tunisian patients with lower urinary symptoms suggestive of benign prostatic hyperplasia].[每日一次服用10毫克阿夫唑嗪对提示良性前列腺增生的突尼斯下尿路症状患者生活质量的影响]
Tunis Med. 2015 Mar;93(3):164-9.
10
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.男性下尿路症状提示良性前列腺增生伴射精功能障碍。
BJU Int. 2009 Oct;104(7):974-83. doi: 10.1111/j.1464-410X.2009.08503.x. Epub 2009 May 7.

引用本文的文献

1
Statins and male sexual health: a retrospective cohort analysis.他汀类药物与男性性健康:一项回顾性队列分析。
J Sex Med. 2015 Jan;12(1):158-67. doi: 10.1111/jsm.12745. Epub 2014 Nov 25.
2
Impact of alfuzosin on sexual function in Taiwanese men with benign prostatic hyperplasia. alfuzosin 对有良性前列腺增生的台湾男性性功能的影响。
Kaohsiung J Med Sci. 2012 Aug;28(8):429-34. doi: 10.1016/j.kjms.2012.02.013. Epub 2012 Jun 12.
3
Integrative medicine: complementary therapies and supplements.整合医学:补充疗法和补充剂。

本文引用的文献

1
Quality of life and sexual function in patients with benign prostatic hyperplasia.良性前列腺增生患者的生活质量与性功能
Rev Urol. 2003 Spring;5(2):72-80.
2
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).欧洲泌尿外科学会(EAU)2004年关于疑似良性前列腺梗阻的男性下尿路症状的评估、治疗及随访指南(BPH指南)
Eur Urol. 2004 Nov;46(5):547-54. doi: 10.1016/j.eururo.2004.07.016.
3
Applicability of biomarkers in the early diagnosis of prostate cancer.
Nat Rev Urol. 2009 Apr;6(4):228-33. doi: 10.1038/nrurol.2009.41.
生物标志物在前列腺癌早期诊断中的适用性。
Expert Rev Mol Diagn. 2004 Jul;4(4):513-26. doi: 10.1586/14737159.4.4.513.
4
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.多沙唑嗪、非那雄胺及联合治疗对良性前列腺增生临床进展的长期影响。
N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656.
5
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).下尿路症状与男性性功能障碍:老年男性多国调查(MSAM-7)
Eur Urol. 2003 Dec;44(6):637-49. doi: 10.1016/j.eururo.2003.08.015.
6
Improvements in benign prostatic hyperplasia-specific quality of life with dutasteride, the novel dual 5alpha-reductase inhibitor.新型双重5α-还原酶抑制剂度他雄胺对良性前列腺增生症患者特定生活质量的改善作用
BJU Int. 2003 Aug;92(3):262-6. doi: 10.1046/j.1464-410x.2003.04310.x.
7
AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.美国泌尿外科学会良性前列腺增生管理指南(2003年)。第1章:诊断与治疗建议。
J Urol. 2003 Aug;170(2 Pt 1):530-47. doi: 10.1097/01.ju.0000078083.38675.79.
8
Safety and tolerability of the dual 5alpha-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia.双重5α-还原酶抑制剂度他雄胺治疗良性前列腺增生的安全性和耐受性
Eur Urol. 2003 Jul;44(1):82-8. doi: 10.1016/s0302-2838(03)00198-2.
9
Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General Practice.在全科医疗中对3228例接受阿夫唑嗪治疗的临床良性前列腺增生症患者进行的三年前瞻性研究。
Prostate Cancer Prostatic Dis. 1998 Sep;1(5):276-283. doi: 10.1038/sj.pcan.4500253.
10
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.1型和2型5-α还原酶双重抑制剂(度他雄胺)在良性前列腺增生男性患者中的疗效与安全性。
Urology. 2002 Sep;60(3):434-41. doi: 10.1016/s0090-4295(02)01905-2.